Correlation Between Kezar Life and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Novo Nordisk AS, you can compare the effects of market volatilities on Kezar Life and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Novo Nordisk.

Diversification Opportunities for Kezar Life and Novo Nordisk

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Kezar and Novo is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Kezar Life i.e., Kezar Life and Novo Nordisk go up and down completely randomly.

Pair Corralation between Kezar Life and Novo Nordisk

Considering the 90-day investment horizon Kezar Life Sciences is expected to generate 1.64 times more return on investment than Novo Nordisk. However, Kezar Life is 1.64 times more volatile than Novo Nordisk AS. It trades about -0.03 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.16 per unit of risk. If you would invest  773.00  in Kezar Life Sciences on August 28, 2024 and sell it today you would lose (26.00) from holding Kezar Life Sciences or give up 3.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kezar Life Sciences  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Kezar Life Sciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life reported solid returns over the last few months and may actually be approaching a breakup point.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kezar Life and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kezar Life and Novo Nordisk

The main advantage of trading using opposite Kezar Life and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Kezar Life Sciences and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device